Header

Overview

Figure 1:
Scheme of the cell surface display of streptavidin

We knew we wanted to bind Nanoparticles to the Bacteria using the very strong interaction between biotin and streptavidin.
Next we needed to decide which strategy would be the best so the E.coli expresses streptavidin on the outer membrane.
E.Coli are Gram-negative bacteria and they have two membranes, an inner one and an outer one, separated by a periplasmic space. Furthermore, the outer membrane is covered with a glycocalix, a layer of sugars.

There exist different ways to express a heterologous protein on the outer membrane of E.coli. Peptides can be fused with outer membrane proteins, or on fimbriae, fused to beta-autotransporters or lipoproteins, as for example the (Lpp)-OmpA protein. But then there is also another promising display system based on the use of ice nucleation protein (INP) from Pseudomonas syringae. Which we decided to use.

Our Biobricks

For Details, please move the cursor onto the image.

Ice nucleation Protein
INP originates from the bacteria Pseudomonas syringae. It is an outer membrane protein. That has succesfully been used for cell surface display of enzymes, antibodies and antigens.

Streptavidin
Streptavidin originates from the bacterium Streptomyces avidinii. It is a tetrameric protein, each of the four subunit can bind one biotin molecule with a very high affinity.
For our Biobricks we used three different kinds of streptavidin.

pBS1C3
The three biobricks were cloned into the standart iGEM backbone plasmid, which contains a chloramphenicol resistance for selection.

We decided to engineer a fusion protein between Ice nucleation protein (INP) and Streptavidin. Because such fusion proteins have been successfully used for cell surface display of enzymes, single-chain antibodies and antigens. So we assumed it would work for streptavidin as well. Especially because Jung et al ([http://www.ncbi.nlm.nih.gov/pubmed/9624691 1]) even succeeded to surface express a functional enzyme, that was much bigger than streptavidin.
Ice nucleation protein is a glycosyl-phosphatidyliositol anchored outer membrane protein, this motif is quite unique in prokaryotes. When it is expressed in E.coli over 90% of INP is found in the outer membrane, Wolber et al ([http://www.pnas.org/content/83/19/7256.short 2]).

Streptavidin
Streptavidin originates from the bacterium Streptomyces avidinii ([http://www.ncbi.nlm.nih.gov/nuccore/A00743.1 NCBI]). It is a tetrameric protien, and each of the four subunits can bind biotin with a very high affinity.

We cloned three Biobricks that contain different versions of streptavidin.

BBa_K1111012
Encodes a fusion protein between INP and a monovalent streptavidin provided by the laboratory of Mark Howarth at Oxford university Department of Biochemistry ([http://users.ox.ac.uk/~bioc0756/MyWebs/activesite/index.htm 3])
BBa_K1111013
Encodes a fusion protein between INP and a dead version of streptavidin. It was designed to serve as a negative control for the microscopy functional assays, because its affinity to biotin is much lower.
BBa_K1111014
Encodes a fusion protein between INP and streptavidin we received in the Biobrick BBa_K283010.

INP-YFP Characterization

There is a Biobrick that contains INP in the iGEM registry (BBa_K523013). It was designed by the Edinburgh 2011 iGEM team. This Biobrick encodes a fusion protein of a truncated and codon optimized INP and yellow fluorescent protein (YFP) under control of the Lac promoter. The INP is truncated, it only contains the first 211 and last 97 amino acids that are normally encoded by the inaK gene. This is enough to target it to the outer membrane.

We improved the Biobrick BBa_523013 by extensively characterizing it.

We used confocal microscopy to see if it was expressed and eventually show surface localization.
Thanks to Thierry Laroche for taking the images with the confocal microscope.

Figure 2:
Confocal image of BBa_K523013 transformed DH5alpha E.coli
A: shows YFP fluorescence (514 nm)
B: zoom of one Bacteria that shows spot of clustered YFP

Looking at E.coli we noticed that fluorescence was localized in specific specks, that the team of Edinburgh didn’t describe. We started looking for an explanation for this phenomena and found in the literature that INP forms aggregates in the cell membrane [http://www.ncbi.nlm.nih.gov/pubmed/2203606 [3]] This suggests that INP also forms aggregates when it is fused to other proteins. We continued characterizing this biobrick by first determing the percentage of bacteria that was fluorescent. We found that approximatively 30% of E.coli expressed YFP.

The team of Edinburgh grew bacteria and lysed them. After centrifugation, they looked where the fluorescence seemed concentrated. On the transformed bacteria, it was mainly the pellet that appeared fluorescent, meaning that the fusion protein was embedded in the membrane. The negative control, in contrast, showed fluorescence in the pellet as well as in the supernatant with the same intensity. This method was used because their microscopy was not good enough.
The confocal microscope was really powerfull. But we too, didn't succeed to proof surface localization of the fusion protein by simply looking at the intrinsic fluorescence of the YFP, because the signal was to diffuse.

So we came up with an alternative strategy: Immunofluorescent assay using an anti-YFP antibody and visualizing it with a inverted microscope.

Figure 3:Inverted microscope composite images of BBa_K523013 transformed DH5alpha E.coli
A: shows YFP fluorescence (514 nm)
B: stained with biotinylated anti-YFP antibody and avidin dylight (650 nm)
C: Merge of A and B, shows colocalization of fluorescent signal

We did an immunofluorescent assay with an anti YFP antibody (Thanks Francesca Volpetti for giving us the antibody). In Figure 3 you can see the results we obtained with microscopy. The YFP signal (Figure 3 A) and the Cy5 signal (The antibody was tagged with NeutrAvidin DylLight Fluorescent Conjugate red, 650 nm from pierce) (Figure 3 B) superimpose nicely (Figure 3 C). Thus proofing that the fusion protein between INP and YFP is exported to the outer membrane.

Results

In the following section, you will find the results concerning our streptavidin cell surface display work.

Our first experimental steps were to perform Polymerase Chain Reactions (PCR) in order to isolate the different streptavidins.

Cloning

Gel 1: 0.8% Gel electrophoresis to verify PCR of Streptavidin Alive coding sequence. Expected frangment size is 384bp and nothing in the reagent negative control.

Gel 2: 0.8% Gel electrophoresis to verify PCR of Streptavidin Dead coding sequence. Expected fragment size is 387bp and nothing in the reagent negative control

Gel 3: 0.8% Gel electrophoresis to verify PCR of Streptavidin iGEM coding sequence. Expected fragment size is 387bp and nothing in the reagent negative control

The previous Gels show that our PCR reactions (68°C annealing temp, primers in registry) to amplify the streptavidin coding sequences went fine. The DNA fragments migrated at the expected sizes written under each images. The PCR to amplify our backbone (see primers in the registry) from the BBa_K523013 biobrick and to add overhangs complementary to the edges of the streptavidin sequences also worked.

With the PCR products we did Gibson Assembly to obtained our desired constructs. The Gibson Assembly reaction worked as expected, we obtained a product around the expected size 4171bp.

Then another way to verify that our Gibson assembly reaction potentially worked was to transform cells with the Gibson products. The transformed DH5α competent cells should be able to grow on an antibiotic medium thanks to the resistance provided by the plasmid. The only problem with this second verification is that the Gibson product could still contain parental plasmid,which insertion in cells can also lead to cells resistance and survival. So to verify if there is a carry over of the initial plasmids, we made controls but here you are not provided with the transformation plates and their controls because they worked as expected.
You can only observe hereafter plates containing cells from the glycerol stocks we made of our gibson products .

Image 1: INP_Streptavidin Alive Gibson transformed cells plated from the glycerol stock

Image 2: INP_Streptavidin Dead Gibson transformed cells plated from the glycerol stock

Image 3: INP_Streptavidin iGEM Gibson transformed cells plated from the glycerol stock

As the other checks did not provide informations about possible mutations, we also sent our constructs for sequencing, using VR and VF2 iGEM primers but also another forward primer we designed ourselves. The sequencing results were also good, the protein is well inserted and there is no frame shift. You can see the sequencing results using the following iGEM registry links: results_ISA ; results_ISD ;results_ISI .

So up to now, with the previous informations we had on our contructs, we could simply conclude that our basic cloning strategy worked.

Then moving on, we needed to test if the protein was expressed, if it was well localised at the outer membrane and the functional. We thus designed immunostaining assays to verify localisation at the outer membrane and biotin-staining assay for the protein functionnality (see protocols). Then we visualized the samples using a NIKON Eclipse TI inverted microscope [http://en.wikipedia.org/wiki/Inverted_microscope] and also a Confocal microscope [http://en.wikipedia.org/wiki/Confocal_microscopy], which is one of the most powerful. unfortunatly for all these assays, we didn't have an appropriate positive control as our constructs were newly designed by ourselves.

Inverted Microscopy

The eight following images represent only the construct ISA. You can observe the bright field images followed by their corresponding composite images (bright field file merged with fluorescent file).

Figure 1.1: Bright field image of ISA cells after overnight incubation with 1mM IPTG and 1hr incubation with biotin conjugated to FITC reporter

Figure 1.2: Composite image of ISA cells after overnight incubation with 1mM IPTG and 1hr incubation with biotin conjugated to FITC reporter

Figure 2.1: Bright field image of ISA cells after overnight incubation with 1mM IPTG and 1hr incubation with biotin conjugated to FITC reporter

Figure 2.2: Composite image of ISA cells after overnight incubation with 1mM IPTG and 1hr incubation with biotin conjugated to FITC reporter

The next images show the competent cells we use as negative controls, in the same conditions as explained above.

Figure 3.1: Bright field image of compentent cells after overnight incubation with 1mM IPTG and 1hr incubation with biotin conjugated to FITC reporter

Figure 3.2: Composite image of competent cells after overnight incubation with 1mM IPTG and 1hr incubation with biotin conjugated to FITC reporter

It was not expected to find a pattern similar to the one found in the cells transformed with our constructs.
These results are followed by the images corresponding to the two other constructs ISD and ISI.

Figure 7.1: Bright field image of ISD cells after 1hr incubation with biotin conjugated to FITC reporter

Figure 7.2: Composite image of ISD cells 1hr incubation with biotin conjugated to FITC reporter

Figure 8.1: Bright field image of ISI cells after 1hr incubation with biotin conjugated to FITC reporter

Figure 8.2: Composite image of ISA cells after 1hr incubation with biotin conjugated to FITC reporter

We thus decided to incubate ISA, ISD, ISI cells and competent cells with the some biotinylated nanoparticles conjugated with TexRed reporter.
This time again you can observe in the following pictures, nanoparticles (red) but and cells, but we cannot tell if they are attached or not.

Figure 9: Composite image of ISA cells 1hr incubation with biotin coated nanoparticules conjugated to TexRed reporter

Figure 10: Composite image of ISD cells 1hr incubation with biotin coated nanoparticules conjugated to TexRed reporter

Figure 11: Composite image of ISI cells 1hr incubation with biotin coated nanoparticules conjugated to TexRed reporter

Figure 12: Composite image of competent cells 1hr incubation with biotin coated nanoparticules conjugated to TexRed reporter

Confocal Microscopy
Focusing on the biotin assays, we did the confocal experiment to better characterize this observed phenotypes. You can observe the results below (Figure 9 to 12).

Figure 13: confocal microscopy image showing ISA cells incubated 1hr with biotin conjugated to FITC reporter

Figure 14: confocal microscopy image showing ISD cells incubated 1hr with biotin conjugated to FITC reporter

Figure 15: confocal microscopy image showing Competent cells incubated 1hr with biotin conjugated to FITC reporter

Figure 16: confocal microscopy image showing streptavidin coated magnetic beads incubated 1hr with biotin conjugated to FITC reporter

To conclude on the confocal microscopy, we were not able to distinguish weather the biotin molecules were inside or on the outside of the cells. And also we can see that some cells in the negative control are fluorescent.

With the previous we cannot make a conclusion on the localisation of our fusion proteins but more, it is hard to say if the protein is indeed expressed.

Growth curve and Western Blot

Figure : WB of the different INP - streptavidin constrcus

We did a western blot seeking for the ~50kDa bands corresponding to our protein. For this experiment we use a FITC conjugated, anti-streptavidin polyclonal Antibody. Despite the gel quality, you can see in the following picture, band of the desired size.

Finally we did a growth curve of the cells containing our constructs. For this last experiment, the cells were inoculated overnigth with 1mM IPTG. In the morning they were ininitially diluted to a certain OD and then the OD was regularly measured. We can see that the insertion of our plasmid affects the growth of E. coli cells.

Here is the nomenclature we will further use:

1)Initially used plasmid:
INP_EYFP Biobrick: BBa_523013
Streptavidin Alive: BBa_K1111010
Streptavidin Dead: BBa_K1111011
Streptavidin iGEM: BBa_K283010.

2) PCR reactions products
INP_construct = BBa_K523013 after PCR without EYFP
SA = Streptavidin Alive; SD = Streptavidin Dead
SI = Streptavidin iGEM.

3) Gibson reaction product names:
ISA = INP_Streptavidin Alive gibson product BBa_K1111012
ISD = INP_Streptavidin Dead gibson productBBa_K1111013
ISI = INP_Streptavidin iGEM BBa_K283010 gibson productBBa_K1111014

Discussion

Our idea was to clone a fusion protein made of INP and Streptavidin that will be able to target streptavidin at the cell surface. This streptavidin could then further be used to attached biotinylated nanoparticules to the cells. We thus designed assays to clone this fusion protein and verify its functionality and localization. For the biotin assay, we were expecting ISA, ISI cells to bind to biotin and ISD, competent cells to not bind to it. We had the right patterns for ISA and ISI. We thus though that we had things working, but by repeating experiments several times and looking carefully at the competent and the ISD cells we found that the fluorescent cells also had the same characteristics as the ISA and ISI cells, which is unfortunately a contradictory result. We also had our immunostaining experiments that didn’t work, but the western blot results were positive. So knowing that we did all this very carefully with a strict scientific approach we came to the conclusion that our protein is expressed but localised inside the cells. It might be that it is not well folded preventing the fusion product to behave exactly like BBa_K523013 protein.

References

[1] Surface display of Zymomonas mobilis levansucrase by using the ice-nucleation protein of Pseudomonas syringae, Jung HC, Lebeault JM, Pan JG. (1998)
[2] Identification and purification of a bacterial ice-nucleation protein, Wolber PK, Deininger CA, Southworth MW, Vanderkerckhove J, van Montagu M and Warren GJ (1986)

[4] Clustering of ice nucleation protein correlates with ice nucleation activity, Mueller GM, Wolber PK, Warren GJ. (1990)

Aknowledgements

Thanks to:
[3] Laboratory of Mark Howarth at Oxford university Department of Biochemistry, for providing us with the cloning plasmids for Streptavidin.
Thierry Laroche for making the images with the confocal microscope.
Francesca Valporetti for providing us with a 1/60 dilution of anti-YFP antibody.